Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity

导出原文传递

翻译打印收藏纠错

作者： Eduardo Burgarelli Lages ^[1] ; Renata Salgado Fernes ; Juliana de Oliveira Silva ; Angelo Malachias de Souza ; Geovanni Dantas Cassali ; Andre Luis Branco de Barros ; Lucas Antonio Mira Ferreira

作者单位： Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais ^[1]

关键词 Doxorubicin Combination therapy Ion-pairing Synergism Antitumor activity Cardiotoxicity

发布时间 2021-06-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Biomedicine & pharmacotherapy =

2020年132卷

110876-110876页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity

Biomedicine & pharmacotherapy =

相似文献

Biomedicine & pharmacotherapy =

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity

Biomedicine & pharmacotherapy =

相似文献

Biomedicine & pharmacotherapy =

相关期刊

检索历史清除